About Us
Sea Run Holdings, Inc is a marine biotechnology company. We discover and develop innovative biologics and therapeutics from the blood of farmed salmon.
Management
- Evelyn S. Sawyer - Ph.D. President and CEO
- Charlton H. Ames -Vice-President Business Development
- Bradford S. Wellman - Chief Financial Officer
- Paul A. Janmey, Ph.D. - Chief Scientist
Collaborations
Sea Run benefits from collaborations with the academic community and industry. Collaborating scientists include:
- Keng Pee Ang, Ph.D. Cooke Aquaculture Ltd. St John NB, Canada
- Lisa A. Flanagan, Ph.D. University of California, Irvine, CA
- Jed B. Gorlin, MD. Memorial Blood Center of Minnesota, Minneapolis, MN
- David F. Meaney, Ph.D. University of Pennsylvania, Philadelphia, PA
- Stephen W. Rothwell, Ph.D. Uniformed Services University of the Health Sciences, Washington, DC
- Raivo Uibo, MD, Ph.D. University of Tartu, Estonia
- Beth A. Winkelstein, Ph.D. University of Pennsylvania, Philadelphia, PA
A joint venture with Cooke Aquaculture Ltd, with operations in Maine, eastern Canada, and Chile provides Sea Run with a large supply of quality-controlled blood.
Our technology has the potential for many applications, and we welcome new collaborations and research partnerships. Please contact Charlton Ames at cames@searunholdings.com.
|
Solutions from the sea
Our technology allows us to turn the blood of farm-raised salmon into therapeutics with proven benefits for the injured central nervous system.
Click to enlarge (pop-up window)
|
100-meter salmon pens in eastern Maine.
|
|
A salmon blood donor.
|
Salmon plasma proteins are purified and processed by Sea Run Holdings, Inc.
|
|
These proteins could transform the treatment of CNS injuries.
|
|
